test

]]>https://dev.proinvestor.com/forum/topic/400863/pharma-juni-2022RSS for NodeSun, 07 Jun 2026 12:12:50 GMTWed, 08 Jun 2022 04:56:34 GMT60Novartis skal fyre 7 pct. af de ansatte
https://www.proinvestor.com/investornyt/843882/novartis-skal-fyre-7-pct-af-de-ansatte

]]>https://dev.proinvestor.com/forum/post/8037610https://dev.proinvestor.com/forum/post/8037610Wed, 29 Jun 2022 09:50:05 GMTLundbeck/SEB: Kursmål løftes til 40 kr. - GENT
https://www.proinvestor.com/investornyt/843327/lundbeck-seb-kursmal-loftes-til-40-kr-gent

]]>https://dev.proinvestor.com/forum/post/8037611https://dev.proinvestor.com/forum/post/8037611Tue, 28 Jun 2022 03:01:05 GMTALK/dir: Peanutvaccine giver god mening - ser godkendelse senest 2030
https://www.proinvestor.com/investornyt/842954/alk-dir-peanutvaccine-giver-god-mening-ser-godkendelse-senest-2030

]]>https://dev.proinvestor.com/forum/post/8037612https://dev.proinvestor.com/forum/post/8037612Mon, 27 Jun 2022 11:59:59 GMTALK igangsætter fase 1-studie med tabletvaccine mod peanutallergi - NY
https://www.proinvestor.com/investornyt/842863/alk-igangsaetter-fase-1-studie-med-tabletvaccine-mod-peanutallergi-ny

]]>https://dev.proinvestor.com/forum/post/8037614https://dev.proinvestor.com/forum/post/8037614Mon, 27 Jun 2022 09:25:54 GMTLundbeck er klar til FDA-ansøgning efter vigtige Alzheimers-data - NY2
https://www.proinvestor.com/investornyt/842756/lundbeck-er-klar-til-fda-ansogning-efter-vigtige-alzheimers-data-ny2

]]>https://dev.proinvestor.com/forum/post/8037613https://dev.proinvestor.com/forum/post/8037613Mon, 27 Jun 2022 03:23:15 GMTLundbeck: Studie af Vyepti publiceres i prestigefyldte The Lancet
https://www.proinvestor.com/investornyt/838454/lundbeck-studie-af-vyepti-publiceres-i-prestigefyldte-the-lancet

]]>https://dev.proinvestor.com/forum/post/8037609https://dev.proinvestor.com/forum/post/8037609Thu, 16 Jun 2022 05:50:25 GMT